Datavault AI and Wellgistics Partner to Develop Blockchain-Enabled PharmacyChain System
TL;DR
Datavault AI's partnership with Wellgistics creates new revenue streams and competitive advantages in the $639 billion prescription drug market through blockchain technology.
Datavault AI's Information Data Exchange platform uses blockchain smart contracts and digital twins to optimize pharmaceutical logistics from manufacturer to patient.
This collaboration enhances prescription drug transparency and efficiency while supporting personalized health recommendations for better patient outcomes.
Datavault AI is building digital twins of patients and logistics systems using blockchain to revolutionize pharmaceutical distribution.
Found this article helpful?
Share it with your network and spread the knowledge!
Datavault AI Inc. has entered a SaaS agreement with Wellgistics Health Inc. to co-develop PharmacyChain, a blockchain-enabled smart contract system designed to optimize prescription distribution from manufacturers to patients. The collaboration leverages Datavault AI's patented Information Data Exchange platform to create secure, token-driven data transfers that enhance transparency and efficiency in pharmaceutical logistics. CEO Nathaniel Bradley stated that the partnership will build digital twins of logistics, delivery systems, and patients, supporting personalized health recommendations and new revenue streams in the $639 billion prescription drug market.
The PharmacyChain system represents a significant advancement in pharmaceutical supply chain management, addressing longstanding challenges in transparency, security, and efficiency that have plagued the industry for decades. Datavault AI's technology suite, which includes the Information Data Exchange platform, enables the creation of digital twins and facilitates the licensing of name, image, and likeness by securely attaching physical real-world objects to immutable metadata objects. This approach fosters responsible AI with integrity while providing comprehensive solutions across multiple industries, including healthcare, biotech, and fintech. The company's cloud-based platform offers AI and Machine Learning automation, third-party integration, detailed analytics, and marketing automation capabilities.
The partnership combines Datavault AI's expertise in AI data experience, valuation, and monetization with Wellgistics' pharmaceutical distribution capabilities. The blockchain-enabled smart contract system aims to revolutionize how prescription drugs move through the supply chain, potentially reducing costs, minimizing errors, and improving patient outcomes through enhanced tracking and verification mechanisms. This collaboration comes at a critical time for the pharmaceutical industry, which faces increasing pressure to improve supply chain security and transparency. The $639 billion prescription drug market represents one of the largest sectors in healthcare, making innovations in distribution technology particularly significant for both industry stakeholders and patients who rely on timely and secure access to medications.
For more information about Datavault AI, visit https://www.datavaultsite.com. Additional news and updates relating to DVLT are available in the company's newsroom at https://ibn.fm/DVLT.
Curated from InvestorBrandNetwork (IBN)
